Did not become law. It stopped in the Senate's Banking & Insurance Committee on May 15, 2023. The 2023–2024 session has ended.
2023–2024 Regular Session
Senate Bill 696
An Act providing for pharmaceutical transparency; establishing the Pharmaceutical Transparency Review Board and providing for its powers and duties; establishing the Pharmaceutical Transparency Review Fund; and imposing a penalty.
Sponsors
Who carried the bill in each chamber, and who signed on. Each name leads to the member's page.
In the Senate
Sponsor
Its course
May 15 to May 15, 2023, on one scale. In the top row each mark is a day something happened; taller marks are busier days.
Each committee stop sits inside its chamber.
Every action1 action on 1 day
In the SenateMay 15 to May 15 · stopped0 days
Banking & InsuranceMay 15 to May 15 · stopped0 days
Text
Each version as the General Assembly printed it.
l9n doesn't hold this bill's text yet.
What happened
In l9n's words, one line for each step. Every action as the General Assembly published it is below.
In the Senate May 15
- May 15Sent to BANKING AND INSURANCE
All 1 actions, as published
- May 15Referred to BANKING AND INSURANCE, May 15, 2023 [Senate]Senate